RxDoctor Payments Data

Hollie Tyler

Family · Las Vegas, NVNPI 1518261858

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $105,985 of the $117,934 with a category attached, or 89.9%. AbbVie accounts for 99.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $45,958 and has fallen 63.5% since, to $16,795 in 2025. Among family clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$117,934in general payments, 2019–2025

Across 260 payments — averaging $453.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$117K
  • Merz North America, Inc.$609
  • Galderma Laboratories, L.p.$238
  • Davol Inc.$40

What the payments were for

  • Speaking & faculty fees$105,98590%
  • Travel & lodging$7,0556%
  • Food & beverage$4,7594%
  • Education$1350%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)230$117,047
Merz North America, Inc.19$609
Galderma Laboratories, L.p.10$238
Davol Inc.1$40

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$117,934 in reported general payments places this provider in the 95th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada

Other family in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →